Biblioteca Humberto Rosselli Quijano
[artículo]
| Título : |
Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia |
| Tipo de documento: |
texto impreso |
| Autores: |
Steven M. Paul, Autor ; Samantha E. Yohn, Autor ; Michael Popiolek, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 611-627 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Espectro de esquizofrenia - otros trastornos psicóticos, Antipsicóticos, Receptores muscarínicos, Síntomas positivos, negativos y Cognitivos |
| Resumen: |
Schizophrenia remains a challenging disease to treat effectively with current antipsychotic medications due to their limited efficacy across the entire spectrum of core symptoms as well as their often burdensome side-effect profiles and poor tolerability. An unmet need remains for novel, mechanistically unique, and better tolerated therapeutic agents for treating schizophrenia, especially those that treat not only positive symptoms but also the negative and cognitive symptoms of the disease. |
| Link: |
./index.php?lvl=notice_display&id=29389 |
in The American Journal of Psychiatry > Año 2022 - Vol. 179 - No. 9 (Septiembre) . - pp. 611-627
|
